Dimerix will receive an upfront payment of $30m from Amicus and up to $75m in development and regulatory milestone payments.

Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and ...

Good morning! Here’s everything you need to know, and some things you don't, before the ASX flings open its doors and begins trading today.

Explore DMX's net worth journey, career success, legal issues, and legacy. Discover how the rap icon went from global fame to ...

Andromeda Metals (ASX:ADN) has pulled off a major breakthrough, with lab tests showing it can produce ultra-high purity 4N ...

Manchester’s Marathon was a massive success over the weekend, we went out into Manchester to ask people on the street why it was such a big deal for the city.

CNBC's Diana Olick joins 'Squawk on the Street' to discuss the latest details on the housing market. It’s a NEXT Weather ...